The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Moringa oleifera as an Anti-Cancer Agent against Breast and Colorectal Cancer Cell Lines
Open accessAbstract
In this study we investigated the anti-cancer effect of Moringa oleifera leaves, bark and seed extracts. When tested against MDA-MB-231 and HCT-8 cancer cell lines, the extracts of leaves and bark showed remarkable anti-cancer properties while surprisingly, seed extracts exhibited hardly any such properties. Cell survival was significantly low in both cells lines when treated with leaves and bark extracts. Furthermore, a striking reduction (about 70-90%) in colony formation as well as cell motility was observed upon treatment with leaves and bark. Additionally, apoptosis assay performed on these treated breast and colorectal cancer lines showed a remarkable increase in the number of apoptotic cells; with a 7 fold increase in MD-MB-231 to an increase of several fold in colorectal cancer cell lines. However, no significant apoptotic cells were detected upon seeds extract treatment. Moreover, the cell cycle distribution showed a G2/M enrichment (about 2-3 fold) indicating that these extracts effectively arrest the cell progression at the G2/M phase. The GC-MS analyses of these extracts revealed numerous known anti-cancer compounds, namely eugenol, isopropyl isothiocynate, D-allose, and hexadeconoic acid ethyl ester, all of which possess long chain hydrocarbons, sugar moiety and an aromatic ring. This suggests that the anti-cancer properties of Moringa oleifera could be attributed to the bioactive compounds present in the extracts from this plant. This is a novel study because no report has yet been cited on the effectiveness of Moringa extracts obtained in the locally grown environment as an anti-cancer agent against breast and colorectal cancers. Our study is the first of its kind to evaluate the anti-malignant properties of Moringa not only in leaves but also in bark. These findings suggest that both the leaf and bark extracts of Moringa collected from the Saudi Arabian region possess anti-cancer activity that can be used to develop new drugs for treatment of breast and colorectal cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clonogenic assay of cells in vitro
Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J., & van Bree, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.339 · Cited by 4,188
CURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,647
Breast Tumor Cell Lines From Pleural Effusions2
Cailleau, R., Young, R., Olivé, M., & Reeves, W. J. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/53.3.661 · Cited by 1,015
Leone, A., Spada, A., Battezzati, A., Schiraldi, A., Aristil, J., & Bertoli, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160612791 · Cited by 802
Natural products in cancer chemotherapy: past, present and future
Mann, J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc723 · Cited by 684
Role of Antioxidant Lycopene in Cancer and Heart Disease
Rao, A. V., & Agarwal, S. (2000) · Journal of the American College of Nutrition · doi:10.1080/07315724.2000.10718953 · Cited by 667
Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review
Mbikay, M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00024 · Cited by 613
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
Health Benefits of Moringa oleifera
Abdull Razis, A. F., Ibrahim, M. D., & Kntayya, S. B. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.20.8571 · Cited by 450
p53 and breast cancer, an update
Lacroix, M., Toillon, R.-A., & Leclercq, G. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01172 · Cited by 380
CRAIG, W. J. (1997) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(97)00765-7 · Cited by 318
Breast cancer—facts and figures
Harvey, J., Down, S., Bright-Thomas, R., Winstanley, J., & Bishop, H. (2013) · Breast Disease Management · doi:10.1093/med/9780199215065.003.0005 · Cited by 286
Berkovich, L., Earon, G., Ron, I., Rimmon, A., Vexler, A., & Lev-Ari, S. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-212 · Cited by 285
Antitumor activity of palmitic acid found as a selective cytotoxic substance in a marine red alga.
Harada, H., Yamashita, U., Kurihara, H., Fukushi, E., Kawabata, J., & Kamei, Y. (2002) · PubMed · Cited by 281
Revealing the Power of the Natural Red Pigment Lycopene
Kong, K.-W., Khoo, H.-E., Prasad, K. N., Ismail, A., Tan, C.-P., & Rajab, N. F. (2010) · Molecules · doi:10.3390/molecules15020959 · Cited by 280
Chemosensitization and Radiosensitization of Tumors by Plant Polyphenols
Garg, A. K., Buchholz, T. A., & Aggarwal, B. B. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1630 · Cited by 278
Soluble Extract from Moringa oleifera Leaves with a New Anticancer Activity
Jung, I. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095492 · Cited by 272
Molecular mechanisms of curcumin action: Gene expression
Shishodia, S. (2013) · BioFactors · doi:10.1002/biof.1041 · Cited by 263
Yoo, C.-B., Han, K.-T., Cho, K.-S., Ha, J., Park, H.-J., Nam, J.-H., Kil, U.-H., & Lee, K.-T. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.11.018 · Cited by 262
ANGIOGENESIS: INITIATION AND CONTROL*
Folkman, J. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb25720.x · Cited by 262
Molecular mechanisms of curcumin action: Signal transduction
Shehzad, A., & Lee, Y. S. (2013) · BioFactors · doi:10.1002/biof.1065 · Cited by 248
Eugenol Causes Melanoma Growth Suppression through Inhibition of E2F1 Transcriptional Activity
Ghosh, R., Nadiminty, N., Fitzpatrick, J. E., Alworth, W. L., Slaga, T. J., & Kumar, A. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411429200 · Cited by 210
Tiloke, C., Phulukdaree, A., & Chuturgoon, A. A. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-226 · Cited by 189
Multiple Molecular and Cellular Mechanisms of Action of Lycopene in Cancer Inhibition
Trejo‐Solís, C., Pedraza‐Chaverrí, J., Torres-Ramos, M., Jiménez‐Farfán, D., Cruz-Salgado, A., Serrano‐García, N., Osorio‐Rico, L., & Sotelo, J. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/705121 · Cited by 187
Kaur, G., Athar, M., & Alam, M. S. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20601 · Cited by 159
Self-citationEugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation
Al-Sharif, I., Remmal, A., & Aboussekhra, A. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-600 · Cited by 158
Lycopene: A Review of Its Potential as an Anticancer Agent
Bhuvaneswari, V., & Nagini, S. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/156801105774574667 · Cited by 154
Pisano, M., Pagnan, G., Loi, M., Mura, M. E., Tilocca, M. G., Palmieri, G., Fabbri, D., Dettori, M. A., Delogu, G., Ponzoni, M., et al. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-8 · Cited by 147
Combining Data from DNA Sequences and Morphology for a Phylogeny of Moringaceae (Brassicales)
Olson, M. E. (2009) · BioOne Complete (BioOne) · doi:10.1043/0363-6445-27.1.55 · Cited by 135
Yamaguchi, F., Takata, M., Kamitori, K., Nonaka, M., Dong, Y., Sui, L., & Tokuda, M. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.2.377 · Cited by 131
Phytochemicals: Health Protective Effects.
Craig, W. J., & Beck, L. L. (1999) · PubMed · Cited by 113
Palrasu, M., Murugan, R. S., Priyadarsini, R. V., Govindarajah, V., & Nagini, S. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.04.010 · Cited by 113
Manikandan, P., Vinothini, G., Priyadarsini, R. V., Prathiba, D., & Nagini, S. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9345-2 · Cited by 107
Colorectal Cancer in the Kingdom of Saudi Arabia: Need for Screening
Mosli, M. H., & Al-Ahwal, M. S. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.8.3809 · Cited by 107
Park, B. S., Song, Y. S., Yee, S.-B., Lee, B. G., Seo, S.-Y., Park, Y. C., Kim, J.-M., Kim, H. M., & Yoo, Y. H. (2005) · APOPTOSIS · doi:10.1007/s10495-005-6074-7 · Cited by 92
The inhibitory effect and possible mechanisms of D-allose on cancer cell proliferation
Sui, L., Dong, Y., Watanabe, Y., Yamaguchi, F., Hatano, N., Tsukamoto, I., Izumori, K., & Tokuda, M. (2005) · International Journal of Oncology · doi:10.3892/ijo.27.4.907 · Cited by 91
Pal, D., Banerjee, S., Mukherjee, S., Roy, A. K., Panda, C. K., & Das, S. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.04.013 · Cited by 87
Ghosh, R., Ganapathy, M., Alworth, W. L., Chan, D. C. F., & Kumar, A. P. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.11.002 · Cited by 70
Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis
Islam, M., Sharma, S., Kumar, B., & Teknos, T. N. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.04.003 · Cited by 61
Self-citationVermeulen, S. J. T., Chen, T. R., Speleman, F., Nollet, F., Roy, F. M. V., & Mareel, M. M. K. (1998) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00081-8 · Cited by 46
RhoC Expression and Head and Neck Cancer Metastasis
Islam, M., Lin, G. C., Brenner, J. C., Pan, Q., Merajver, S. D., Hou, Y., Kumar, P., & Teknos, T. N. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0512 · Cited by 36
Self-citationEmmanuel, S., & Abubakar, S. (2014) · HAL · Cited by 23
The mechanism of apoptosis induced by eugenol in human osteosarcoma cells
Shin, S., Park, J.-H., Kim, G., et al. (2007) · Cited by 22
Epidermal Growth Factor Stimulates Phospholipase Cγ1 in Cultured Rabbit Corneal Epithelial Cells
Islam, M., & Akhtar, R. A. (2000) · Experimental Eye Research · doi:10.1006/exer.1999.0783 · Cited by 22
Self-citationSafety and Efficacy of Moringa oleifera Lamarck (1785) — Therapeutic and Toxicological Properties
Ferreira, P. M. P., de Araújo, É. J. F., Silva, J. D. N., de Freitas, R. M., Costa, N. D. D. J., Oliveira, S. F. D. C., Pereira, J. B. A., Pinheiro, J. A. F., de Abreu, M. C., & Pessoa, C. (2014) · InTech eBooks · doi:10.5772/58627 · Cited by 7
Cited by
Moringa Genus: A Review of Phytochemistry and Pharmacology
Abd Rani, N. Z., Husain, K., & Kumolosasi, E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00108 · Cited by 425
Moringa oleifera Seeds and Oil: Characteristics and Uses for Human Health
Leone, A., Spada, A., Battezzati, A., Schiraldi, A., Aristil, J., & Bertoli, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122141 · Cited by 403
Nutraceutical or Pharmacological Potential of Moringa oleifera Lam.
Kou, X., Li, B., Olayanju, J., Drake, J., & Chen, N. (2018) · Nutrients · doi:10.3390/nu10030343 · Cited by 375
Falowo, A. B., Mukumbo, F. E., Idamokoro, E. M., Lorenzo, J. M., Afolayan, A. J., & Muchenje, V. (2018) · Food Research International · doi:10.1016/j.foodres.2017.12.079 · Cited by 302
Plant-derived bioactive compounds in colon cancer treatment: An updated review
Esmeeta, A., Adhikary, S., Dharshnaa, V., Swarnamughi, P., Ummul Maqsummiya, Z., Banerjee, A., Pathak, S., & Duttaroy, A. K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113384 · Cited by 293
Metadata
- Authors
- Al-Asmari, A. K., Albalawi, S. M., Athar, M. T., Khan, A. Q., Al-Shahrani, H., & Islam, M.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-08-19
- Volume
- 10
- Issue
- 8
- Pages
- e0135814
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1127309197
- Cited by
- 340
- References
- 45
- FWCI
- 20.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.